We are live on ! Find out more
PTLA

Portola Pharmaceuticals, Inc.
PTLA

Delisted

PTLA was delisted on the 1st of July, 2020.

Back to rankings

133 hedge funds and large institutions have $1.26B invested in Portola Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 19 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 12

168% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 19

68% more call options, than puts

Call options by funds: $962K | Put options by funds: $572K

34% more capital invested

Capital invested by funds: $938M → $1.26B (+$322M)

23% more funds holding

Funds holding: 108 → 133 (+25)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
133
Holders Change
+25
Holders Change %
+23.15%
% of All Funds
3.55%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
39
Increased
51
Reduced
19
Closed
12
Calls
$962K
Puts
$572K
Net Calls
+$390K
Net Calls Change
+$81K

Top Buyers

Rank Fund Capital Flow
1
Temasek Holdings
Temasek Holdings
Singapore
+$44.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.4M
3
SCM
Scopia Capital Management
New York
+$28.7M
4
State Street
State Street
Massachusetts
+$19.2M
5
Citadel Advisors
Citadel Advisors
Florida
+$16.8M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$8.12M
2
JP Morgan Chase
JP Morgan Chase
New York
-$4.32M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.04M
4
EAM
EverPoint Asset Management
Connecticut
-$3.79M
5
Millennium Management
Millennium Management
New York
-$3.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
51
Sphera Funds Management
Israel
$1.98M +$1.95M +70,000 New
Macquarie Group
52
Macquarie Group
Australia
$1.83M +$120K +4,301 +7%
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$1.7M +$1.59M +57,297 New
TA
54
Teachers Advisors
New York
$1.7M +$223K +8,014 +15%
HCM
55
Highbridge Capital Management
New York
$1.67M +$1.64M +59,031 New
NIP
56
Nicholas Investment Partners
California
$1.57M +$1.55M +55,626 New
TC
57
TFS Capital
Pennsylvania
$1.42M +$1.08M +38,784 +345%
CC
58
CQS Cayman
Cayman Islands
$1.42M +$1.39M +50,000 New
HCMT
59
Highland Capital Management (Texas)
Texas
$1.41M +$1.38M +49,800 New
NFA
60
Nationwide Fund Advisors
Ohio
$1.4M +$116K +4,189 +9%
Invesco
61
Invesco
Georgia
$1.3M +$1.27M +45,755 New
ProShare Advisors
62
ProShare Advisors
Maryland
$1.17M +$150K +5,393 +15%
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
$1.12M +$1.1M +39,634 New
AIG
64
American International Group
New York
$1.1M +$396K +14,232 +57%
CS
65
Credit Suisse
Switzerland
$1.1M +$558K +20,081 +107%
3NC
66
300 North Capital
California
$1.07M +$1.81K +65 +0.2%
Swiss National Bank
67
Swiss National Bank
Switzerland
$1.06M +$170K +6,100 +19%
CWG
68
C WorldWide Group
Denmark
$1.05M -$443K -15,919 -30%
WSA
69
Wall Street Associates
California
$1.01M +$991K +35,634 New
American Century Companies
70
American Century Companies
Missouri
$986K +$42.2K +1,519 +5%
MLICM
71
Metropolitan Life Insurance Company (MetLife)
New York
$942K +$127K +4,570 +16%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$936K +$98.1K +3,530 +12%
USAA
73
United Services Automobile Association
Texas
$856K +$554K +19,930 +193%
D.E. Shaw & Co
74
D.E. Shaw & Co
New York
$825K +$378K +13,582 +87%
TRSOTSOK
75
Teachers Retirement System of the State of Kentucky
Kentucky
$793K – – –
1 2
3
4 5

PTLA Hedge Fund Activity: Q4 2014 in Review

133 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q4 2014, worth a combined $1.26B — up 34% from $938M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new PTLA positions and 12 closed out — a net gain of 27 holders — while 51 added to existing stakes and 19 trimmed.

The largest buyer was Temasek Holdings, adding an estimated $44.5M. The largest seller was Sectoral Asset Management, cutting an estimated $8.12M.

  • 133 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q4 2014, up from 108 in Q3 2014.
  • Funds reported $1.26B of Portola Pharmaceuticals, Inc. stock for Q4 2014, up 34% quarter-over-quarter.
  • 39 funds opened new Portola Pharmaceuticals, Inc. positions in Q4 2014 and 12 closed out, a net change of +27 holders.
  • The largest Portola Pharmaceuticals, Inc. buyer in Q4 2014 was Temasek Holdings, an estimated $44.5M added.
  • The largest Portola Pharmaceuticals, Inc. seller in Q4 2014 was Sectoral Asset Management, an estimated $8.12M sold.

Based on aggregated 13F filings for Q4 2014.